Managers / Q4 2019 · view latest →
KNOTT DAVID M
CIK 0000808722
Summary
Knott David M reported $247M in U.S.-listed holdings across 152 positions for Q4 2019.
Its largest position, LGND, represents 14.5% of the portfolio.
Compared with Q3 2019, the fund opened 11 new positions and exited 16.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 72.5% · $179M
- MLP · 7.4% · $18M
- Ltd Part · 7.0% · $17M
- Other · 6.9% · $17M
- PUBLIC · 5.5% · $14M
- Other · 0.7% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| Fannie Mae Float Series F | NEW | +81.9K | 81.9K | +$2M | $2M |
| Alkermes PLC | NEW | +43.1K | 43.1K | +$879,000 | $879,000 |
| Fannie Mae Float - Series G | NEW | +22.5K | 22.5K | +$393,000 | $393,000 |
| uniQure N.V. | NEW | +4.9K | 4.9K | +$351,000 | $351,000 |
| Alimera Sciences, Inc. | NEW | +45.2K | 45.2K | +$342,000 | $342,000 |
| COLLCollegium Pharmaceutical, Inc. | NEW | +12.5K | 12.5K | +$257,000 | $257,000 |
| Strongbridge Biopharma PLC | NEW | +100.0K | 100.0K | +$209,000 | $209,000 |
| VLYValley National Bancorp | NEW | +12.5K | 12.5K | +$143,000 | $143,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2021 | $275M | 197 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $281M | 195 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $234M | 166 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $221M | 145 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $170M | 135 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $183M | 127 | Aug 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $158M | 156 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $247M | 152 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $238M | 157 | Nov 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $237M | 148 | Aug 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $251M | 143 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $213M | 133 | Feb 12, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- DORSET MANAGEMENT CORP028-10281
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.